Spire Healthcare Group PLC · LSE:SPI

Spire Healthcare — Investor Presentation (October 2010)

63 slides from Spire Healthcare's investor presentation, Oct 20, 2010

  1. Slide 1: Cardiac Arrhythmias: An Update

    Cardiac Arrhythmias: An Update Dr N.M.Gandhi Consultant Cardiologist Spire Gatwick Park Hospital, Horley East Surrey Hospital, Redhill Royal Sussex County Hospital, Brighton

  2. Slide 2: Objectives

    Objectives • Identify common arrhythmias encountered by the family physician • Discuss initial Mg options • AF and Ventricular arrhythmias case studies • Which patients needs to be referred? ECG examples

  3. Slide 3: The Conduction System

    THE CONDUCTION SYSTEM

  4. Slide 4: Atrial Depolarization

    Atrial Depolarization

  5. Slide 5: Ventricular Depolarization

    Ventricular Depolarization

  6. Slide 6: Cardiac Arrhythmias

    CARDIAC ARRHYTHMIAS Disturbances of either : • Impulse generation • Impulse propagation

  7. Slide 7: Electrophysiologic Principles: Arrhythmias

     ELECTROPHYSIOLOGIC A R PRINCIPLES R H Y  BRADYARRHYTHMIAS T H M • SINUS NODE DYSFUNCTION I • AV CONDUCTION DISTURBANCES A S  TACHYARRHYTMIAS •ATRIAL TACHYCARDIAS •VENTRICULAR TACHYCARDIA

  8. Slide 8: Bradyarrhythmias

    Bradyarrhythmias • Impulse formation: – Decreased automaticity: Sinus bradycardia • Impulse conduction: – Conduction blocks: 1º, 2º, 3º AV blocks

  9. Slide 9: Tachyarrythmias

    Tachyarrythmias • Impulse formation – Enhanced automaticity: • Sinus node: sinus tachycardia • Ectopic focus: Ectopic atrial tachycardia – Triggered activity • Early afterdepolarization: torsades de pointes • Digitalis-induced SVT • Impulse conduction – Reentry: Paroxysmal SVT, atrial flutter and fi

  10. Slide 10: Normal Sinus Rhythm

    Normal Sinus Rhythm www.uptodate.com Implies normal sequence of conduction, originating in the sinus node and proceeding to the ventricles via the AV node and His-Purkinje system. EKG Characteristics: Regular narrow-complex rhythm Rate 60-100 bpm Each QRS complex is proceeded by a P wave P wave is u

  11. Slide 11: PAC

    PAC • Benign, common cause of perceived irregular rhythm • Can cause sxs: “skipping” beats, palpitations • No treatment, reassurance • With sxs, may advise to stop smoking, decrease caffeine and ETOH • Can use beta-blockers to reduce frequency

  12. Slide 12: PVC

    PVC • Extremely common throughout the population, both with and without heart disease • Usually asymptomatic, except rarely dizziness or fatigue in patients that have frequent PVCs and significant LV dysfunction

  13. Slide 13: PVC

    PVC • Reassurance • Optimize cardiac and pulmonary disease management • Beta-blocker • Ablation in a small number of cases

  14. Slide 14: Bradyarrhythmias

    Bradyarrhythmias • Impulse formation: – Decreased automaticity: Sinus bradycardia • Impulse conduction: – Conduction blocks: 1º, 2º, 3º AV blocks

  15. Slide 15: Sinus Bradycardia

    Sinus Bradycardia • HR< 60 bpm; every QRS narrow, preceded by p wave • Can be normal in well-conditioned athletes • HR can be 30 bpm in adults during sleep, with up to 2 sec pauses

  16. Slide 16: Sinus arrhythmia

    Sinus arrhythmia • Usually respiratory--Increase in heart rate during inspiration • Exaggerated in children, young adults and athletes—decreases with age • Usually asymptomatic, no treatment or referral • Can be non-respiratory, often in normal or diseased heart, seen in digitalis toxicity • Referra

  17. Slide 17: Sick Sinus Syndrome

    Sick Sinus Syndrome •All result in bradycardia •Sinus bradycardia with a sinus pause •Often result of tachy-brady syndrome: where a burst of atrial tachycardia (such as afib) is then followed by a long, symptomatic sinus pause/arrest, with no breakthrough junctional rhythm.

  18. Slide 18: 1st Degree AV Block

    1st Degree AV Block • PR interval >200ms • If accompanied by wide QRS, refer to cardiology, high risk of progression to 2nd and 3rd deg block • Otherwise, benign if asymptomatic

  19. Slide 19: 2nd Degree AV Block Mobitz type I (Wenckebach)

    2nd Degree AV Block Mobitz type I (Wenckebach) • Progressive PR longation, with eventual non-conduction of a p wave • May be in 2:1 or 3:1

  20. Slide 20: 2nd degree block Type II (Mobitz 2)

    2nd degree block Type II (Mobitz 2) • Normal PR intervals with sudden failure of a p wave to conduct • Usually below AV node and accompanied by BBB or fascicular block • Often causes pre/syncope; exercise worsens sxs • Generally need pacing, possibly urgently if symptomatic

  21. Slide 21: 3rd Degree AV Block

    3rd Degree AV Block • Complete AV disassociation, HR is a ventricular rate • Will often cause dizziness, syncope, angina, heart failure • Can degenerate to Vtach and Vfib • Will need pacing, urgent referral

  22. Slide 22: Tachyarrythmias

    Tachyarrythmias • Impulse formation – Enhanced automaticity: • Sinus node: sinus tachycardia • Ectopic focus: Ectopic atrial tachycardia – Triggered activity • Early afterdepolarization: torsades de pointes • Digitalis-induced SVT • Impulse conduction – Reentry: Paroxysmal SVT, atrial flutter and fi

  23. Slide 23: Supraventricular Tachycardias

    SUPRAVENTRICULAR T. • Sinus Tachycardia • Atrial flutter • Atrial fibrilation • Paroxysmal Supraventricular • Multifocal Atrial T. • Preexcitation Syndrome (Wolff-Parkinson- white Sy.)

  24. Slide 24: Sinus tachycardia

    Sinus tachycardia • HR > 100 bpm, regular • Often difficult to distinguish p and t waves

  25. Slide 25: Paroxysmal Supraventricular T.

    Paroxysmal Supraventricular T. • Sudden onset and termination • Atrial rates of 140 to 250 /min • Normal QRS complexes • The mechanism is most often reentry.

  26. Slide 26: Paroxysmal Supraventricular Tachycardia

    Paroxysmal Supraventricular Tachycardia • Refers to supraventricular tachycardia other than afib, aflutter and MAT • Usually due to reentry—AVNRT or AVRT

  27. Slide 27: PSVT

    PSVT • CSM or adenosine commonly terminate the arrhythmia, esp, AVRT or AVNRT • Can also use CCB or beta blockers to terminate, if available • Counsel to avoid triggers, caffeine, Etoh, pseudoephedrine, stress

  28. Slide 28: Multifocal Atrial T.

    Multifocal Atrial T. • Is due to enchanced automaticity within the atria, resulting in abnormal discharges from several ectopic foci • Most often occurs in the setting of severe pulmonary disease and hypoxemia. • EKG: irregular rhythm with multiple (at leats 3) P waves morphologies

  29. Slide 29: Atrial flutter

    Atrial flutter • Is caracterized by rapid coarse “sawtooth” appearing atrial activity, at rate of 250 to 350 x min. – Many of these fast impulses reach the AV node during its refractory period, so that the ventricular rate is generally lower. • Frequently it degenerates into atrial fibrilation – The

  30. Slide 30: Preexcitation Syndrome

    Preexcitation Syndrome • Wolff-Parkinson-White Syndrome • EKG: Although different types of bypass tracts have been identified, the bundle of Kent, is the most common and can usually conduct in both the anterograde and retrograde directions.

  31. Slide 31: Atrial Fibrillation

    Atrial Fibrillation • Irregular rhythm • Absence of definite p waves • Narrow QRS • Can be accompanied by rapid ventricular response

  32. Slide 32: Atrial fibrillation management

    Atrial fibrillation-- management • Rhythm vs Rate control—if onset is within last 24-48 hours, may be able to arrange cardioversion—use heparin around procedure • Need TEE if valvular disease (high risk of thrombus) • If unable to definitely conclude onset in last 24-48 hours: need 4-6 weeks of anti

  33. Slide 33: Atrial Fibrillation: Clinical Problems

    Atrial Fibrillation: Clinical Problems • Embolism and stroke (presumably due to LA clot) • Acute hospitalization with onset of symptoms • Anticoagulation, especially in older patients (> 75 yr.) • Congestive heart failure – Loss of AV synchrony – Loss of atrial “kick” – Rate-related cardiomyopathy d

  34. Slide 34: AF: Medical Management

    AF: Medical Management • Treatment of underlying cause • Ventricular rate control • Anticoagulation • Antiarrhythmics with a view to restore sinus rhythm

  35. Slide 35: Control of Ventricular Rate in Atrial Fibrillation

    Control of Ventricular Rate in Atrial Fibrillation • Betablockers • Calcium channel blockers Verapamil, diltiazem • Digoxin • Amiodarone

  36. Slide 36: Anticoagulation

    Anticoagulation

  37. Slide 37: Anticoagulation

    Anticoagulation • Assessment of bleeding risk should be part of the clinical assessment of AF patients prior to starting anticoagulation • Antithrombotic benefits and potential bleeding risks of long-term coagulation should be explained and discussed with the patient • Aim for a target INR of betwee

  38. Slide 38: CHADS2 scoring

    CHADS 2 scoring CCF 1 point Hypertension 1 point Age > 75 1point Diabetes 1 point Stroke/TIA 2 points • Any patients with AF with a score of =/>2 would benefit from being on Warfarin

  39. Slide 39: Cardioversion

    Cardioversion

  40. Slide 40: Cardioversion

    Cardioversion • Cardioversion results in SR in at least 90% of cases • SR is only maintained in 30-50% at one year • Class 1a, 1c and III agents increase likelihood of maintained SR from 30-50% to 50-70% at one year

  41. Slide 41: Follow-up

    Follow-up • Follow-up after cardioversion should take place at 1 month, and the frequency of subsequent reviews should be tailored to the patient • Reassess the need for anticoagulation at each review

  42. Slide 42: Catheter Ablation for AF

    Catheter Ablation for AF

  43. Slide 43: AF termination during PV isolation

    AF termination during PV isolation (a) Baseline (CL 171 ms)

  44. Slide 44: AF Ablation

    AF Ablation • Success rates – approx 70% but may require repeat procedure – Often increase in symptoms for first 3-6 months after procedure does not indicate failure • Risks – damage to existing conduction mandating pacing – Cardiac perforation/tamponade – Bleeding – Stroke/thromboembolism – Death

  45. Slide 45: Catheter Ablation: Indications

    Catheter Ablation: Indications • Symptomatic patients • Refractory to Antiarrhythmics • Medical therapy contraindicated due to co- morbidities or intolerance NICE 2006

  46. Slide 46: Which AF patients need Specialist Referral?

    Which AF patients need Specialist Referral? • Patients with: - WPW syndrome - Uncontrolled ventricular rate (> 200/min) - Tachy-brady syndrome - For rhythm control strategy - CCF - Intolerant to Drugs - Invasive options

  47. Slide 47: Ventricular Arrhythmias

    VENTRICULAR ARRHYTHMIAS • Ventricular tachycardia • Torsades De Pointes • Ventricular fibrillation

  48. Slide 48: Ventricular tachycardia

    Ventricular tachycardia • Is divided in 2 categories: – If it persist for more than 30 seconds “sustained VT” – Less than 30 seconds: “nonsustained VT” • Symptoms vary depending on the duration. – Major manifestations are hypotension and loss of consciousness.

  49. Slide 49: Non-sustained ventricular tachycardia

    Non-sustained ventricular tachycardia • Need to exclude heart disease with Echo and stress testing • May need anti-arrhythmia treatment if sxs • In presence of heart disease, increased risk of sudden death • Need referral for EPS and/or prolonged Holter monitoring • ICD may be life saving

  50. Slide 50: Torsades De Pointes

    Torsades De Pointes • Varying amplitudes of the QRS. • It can be produced by afterdepolarizations (triggered activity). • Particularly in prolonged QT interval. • Occur with some drugs (quinidine), electrolite disturbances, and congenital prolongation of the QT interval.

  51. Slide 51: Specialist Referral: ECG Examples

    Specialist Referral ECG Examples

  52. Slide 52: Supraventricular Tachycardia (SVT)

  53. Slide 53: satibaibsypeneseeatagead i

    satibaibsypeneseeatagead i ia rg eet eat aue f HATH teeth lle ad pigar eens te pips} caane os Tet TR be eee b186) 8 soe tt 3 ae oe ee ee

  54. Slide 54: tt

    tt

  55. Slide 55: Slide 55

  56. Slide 56: Slide 56

  57. Slide 57: Slide 57

  58. Slide 58: con

    con C4 Savi diemali VR Gee eee | aVF : A 1 | r] ae | | of | | |

  59. Slide 59: Lemme WKAal : | d A,

    Lemme WKAal : | d A, yy Lanapaiannrssa h H WU. ii ii WWW

  60. Slide 60: Slide 60

  61. Slide 61: OKT. 13:

    49:1 OKT. 27 13: 23 38

  62. Slide 62: Slide 62

  63. Slide 63: Contact

    Contact... * E-mail: [email protected] [email protected] * Fax: 01737 231938 * Phone: Spire - 01293 785511 ESH - 01737 768511, ext.6333

Spire Healthcare Group — Investor Presentation (October 2010) on 6ix